We are a biopharmaceutical company developing innovative and biosimilar – biologic medical product – technologies for clinical development and large-scale production.
We are biopharmaceutical company developing innovative and biosimilar biological drug product technologies for clinical development and large-scale production.
Our target is to bring our product pipeline to the pharmaceutical market. We are looking for cooperation with large and mid-size pharma companies with strong global marketing presence, who do not have internal capabilities or capacities to develop and (or) produce the material for clinical development or commercial supply of the registered drug substance.
As we are a CDMO, we support the global pharmaceuticals market with the capability to develop biopharmaceuticals from the gene to the manufacturing of the final drug product form.
Total area of the
From design to production only 5 years
202 mln. € „Celltechna“ infrastructure investments